Methotrexate Tablet
Product Images NDC 0904-7141

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 0904-7141). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (2a6afc4c 819d 4ba9 8040 4504519c116a 00)

Label for Methotrexate Tablets, USP 2.5 mg oral tablets by Major Pharmaceuticals. The unit dose package contains 20 tablets with directions to dispense with patient information. The label includes warnings about methotrexate toxicity and detailed manufacturing and distribution information.*

FDA Label Image

Image (4b6213e6 Fa3c 4aff Bd85 46d17afa569d 01)

Chemical structure of methotrexate showing its molecular components and bonds, including nitrogen-containing rings and sodium carboxylate groups, consistent with the active ingredient methotrexate in tablet form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.